Intellia Therapeutics (NTLA) Common Equity (2015 - 2026)
Intellia Therapeutics' Common Equity came in at $727.71 million for Q2 2026, compared with -$715.26 million a year earlier and up 17.2% from the prior quarter.
Powered by 
Analysis
Intellia Therapeutics (NTLA) Common Equity (2015 - 2026) Analysis & Trends
At the end of FY2025, Intellia Therapeutics' Common Equity was $671.39 million, down 23.0% from FY2024.
- Common Equity has declined in each of the last three years, though with a five-year compound annual growth rate of 5.0% (FY2020 to FY2025).
- Going back by year, Common Equity was $871.96 million in FY2024 (-17.0%), $1.05 billion in FY2023 (-15.0%), $1.24 billion in FY2022 (+18.8%) and $1.04 billion in FY2021 (+97.4%).
- The five-year range for quarterly Common Equity is -$715.26 million (Q2 2025) to $1.24 billion (Q4 2022).
- The fastest year-over-year change in Common Equity over five years came in Q3 2021 (growth of 235.9%), and the weakest in Q3 2022 (a decline of 25.5%).
- Business Quant data shows NTLA's Common Equity at $620.94 million (Q1 2026), $671.39 million (Q4 2025) and $748.42 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Intellia Therapeutics | 1.57 Bn | -208.95 Mn | - | 727.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 727.71 Mn |
| Mar 31, 2026 | 620.94 Mn |
| Dec 31, 2025 | 671.39 Mn |
| Sep 30, 2025 | 748.42 Mn |
| Jun 30, 2025 | -715.26 Mn |
| Mar 31, 2025 | 779.92 Mn |
| Dec 31, 2024 | 871.96 Mn |
| Sep 30, 2024 | 962.62 Mn |
| Jun 30, 2024 | 971.06 Mn |
| Mar 31, 2024 | 1.04 Bn |
| Dec 31, 2023 | 1.05 Bn |
| Sep 30, 2023 | 1.04 Bn |
| Jun 30, 2023 | 1.10 Bn |
| Mar 31, 2023 | 1.19 Bn |
| Dec 31, 2022 | 1.24 Bn |
| Sep 30, 2022 | 824.95 Mn |
| Jun 30, 2022 | 880.55 Mn |
| Mar 31, 2022 | 953.75 Mn |
| Dec 31, 2021 | 1.04 Bn |
| Sep 30, 2021 | 1.11 Bn |
API Access
Intellia Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=NTLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "NTLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=NTLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();